0001209191-22-003192.txt : 20220113 0001209191-22-003192.hdr.sgml : 20220113 20220113163326 ACCESSION NUMBER: 0001209191-22-003192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220111 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEALY JAMES CENTRAL INDEX KEY: 0001245624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41201 FILM NUMBER: 22529394 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 4-250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CinCor Pharma, Inc. CENTRAL INDEX KEY: 0001868734 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 8445311834 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-11 0 0001868734 CinCor Pharma, Inc. CINC 0001245624 HEALY JAMES C/O CINCOR PHARMA, INC 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 1 0 1 0 Common Stock 2022-01-11 4 C 0 5248949 A 5248949 I By Sofinnova Venture Partners X, L.P. Common Stock 2022-01-11 4 P 0 325000 16.00 A 5573949 I By Sofinnova Venture Partners X, L.P. Series A Preferred Stock 2022-01-11 4 C 0 13571428 0.00 D Common Stock 3991596 0 I By Sofinnova Venture Partners X, L.P. Series B Preferred Stock 2022-01-11 4 C 0 4275000 0.00 D Common Stock 1257353 0 I By Sofinnova Venture Partners X, L.P. Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date. The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. /s/ Cathy Rude, Attorney-in-Fact 2022-01-13